{"pmid":32286155,"title":"Significance of Serology Testing to Assist Timely Diagnosis of SARS-CoV-2 infections: Implication from a Family Cluster.","text":["Significance of Serology Testing to Assist Timely Diagnosis of SARS-CoV-2 infections: Implication from a Family Cluster.","Confirmative diagnosis of SARS-CoV-2 infections has been challenged due to unsatisfactory positive rate of molecular assays. Here we identified a family cluster of SARS-CoV-2 infections, with five of six family members were SARS-CoV-2-specific immunoglobin serology testing positive, while molecular assays only detected two of this five patients even repeated twice. We comprehensively analyzed this familial cluster of cases based on the clinical characteristics, chest CT images, SARS-CoV-2 molecular detection results, and serology testing results. At last, two patients were diagnosed with COVID-19, two were suspected of COVID-19, and two were considered close contacts. Our results emphasized the significance of serology testing to assist timely diagnosis of SARS-CoV-2 infections, especially for COVID-19 close contacts screening.","Emerg Microbes Infect","Xu, Yan","Xiao, Meng","Liu, Xinchao","Xu, Shengyong","Du, Tiekuan","Xu, Jun","Yang, Qiwen","Xu, Yingchun","Han, Yang","Li, Taicheng","Zhu, Huadong","Wang, Mengzhao","32286155"],"abstract":["Confirmative diagnosis of SARS-CoV-2 infections has been challenged due to unsatisfactory positive rate of molecular assays. Here we identified a family cluster of SARS-CoV-2 infections, with five of six family members were SARS-CoV-2-specific immunoglobin serology testing positive, while molecular assays only detected two of this five patients even repeated twice. We comprehensively analyzed this familial cluster of cases based on the clinical characteristics, chest CT images, SARS-CoV-2 molecular detection results, and serology testing results. At last, two patients were diagnosed with COVID-19, two were suspected of COVID-19, and two were considered close contacts. Our results emphasized the significance of serology testing to assist timely diagnosis of SARS-CoV-2 infections, especially for COVID-19 close contacts screening."],"journal":"Emerg Microbes Infect","authors":["Xu, Yan","Xiao, Meng","Liu, Xinchao","Xu, Shengyong","Du, Tiekuan","Xu, Jun","Yang, Qiwen","Xu, Yingchun","Han, Yang","Li, Taicheng","Zhu, Huadong","Wang, Mengzhao"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32286155","week":"202016|Apr 13 - Apr 19","doi":"10.1080/22221751.2020.1752610","source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1664071627107729408,"score":8.233237,"similar":[{"pmid":32267220,"title":"Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients.","text":["Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients.","A new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has recently emerged to cause a human pandemic. Although molecular diagnostic tests were rapidly developed, serologic assays are still lacking, yet urgently needed. Validated serologic assays are needed for contact tracing, identifying the viral reservoir, and epidemiologic studies. We developed serologic assays for detection of SARS-CoV-2 neutralizing, spike protein-specific, and nucleocapsid-specific antibodies. Using serum samples from patients with PCR-confirmed SARS-CoV-2 infections, other coronaviruses, or other respiratory pathogenic infections, we validated and tested various antigens in different in-house and commercial ELISAs. We demonstrated that most PCR-confirmed SARS-CoV-2-infected persons seroconverted by 2 weeks after disease onset. We found that commercial S1 IgG or IgA ELISAs were of lower specificity, and sensitivity varied between the 2 assays; the IgA ELISA showed higher sensitivity. Overall, the validated assays described can be instrumental for detection of SARS-CoV-2-specific antibodies for diagnostic, seroepidemiologic, and vaccine evaluation studies.","Emerg Infect Dis","Okba, Nisreen M A","Muller, Marcel A","Li, Wentao","Wang, Chunyan","GeurtsvanKessel, Corine H","Corman, Victor M","Lamers, Mart M","Sikkema, Reina S","de Bruin, Erwin","Chandler, Felicity D","Yazdanpanah, Yazdan","Le Hingrat, Quentin","Descamps, Diane","Houhou-Fidouh, Nadhira","Reusken, Chantal B E M","Bosch, Berend-Jan","Drosten, Christian","Koopmans, Marion P G","Haagmans, Bart L","32267220"],"abstract":["A new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has recently emerged to cause a human pandemic. Although molecular diagnostic tests were rapidly developed, serologic assays are still lacking, yet urgently needed. Validated serologic assays are needed for contact tracing, identifying the viral reservoir, and epidemiologic studies. We developed serologic assays for detection of SARS-CoV-2 neutralizing, spike protein-specific, and nucleocapsid-specific antibodies. Using serum samples from patients with PCR-confirmed SARS-CoV-2 infections, other coronaviruses, or other respiratory pathogenic infections, we validated and tested various antigens in different in-house and commercial ELISAs. We demonstrated that most PCR-confirmed SARS-CoV-2-infected persons seroconverted by 2 weeks after disease onset. We found that commercial S1 IgG or IgA ELISAs were of lower specificity, and sensitivity varied between the 2 assays; the IgA ELISA showed higher sensitivity. Overall, the validated assays described can be instrumental for detection of SARS-CoV-2-specific antibodies for diagnostic, seroepidemiologic, and vaccine evaluation studies."],"journal":"Emerg Infect Dis","authors":["Okba, Nisreen M A","Muller, Marcel A","Li, Wentao","Wang, Chunyan","GeurtsvanKessel, Corine H","Corman, Victor M","Lamers, Mart M","Sikkema, Reina S","de Bruin, Erwin","Chandler, Felicity D","Yazdanpanah, Yazdan","Le Hingrat, Quentin","Descamps, Diane","Houhou-Fidouh, Nadhira","Reusken, Chantal B E M","Bosch, Berend-Jan","Drosten, Christian","Koopmans, Marion P G","Haagmans, Bart L"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32267220","week":"202015|Apr 06 - Apr 12","doi":"10.3201/eid2607.200841","keywords":["COVID-19","ELISA","HCoV","RBD","SARS-CoV-2","Severe acute respiratory syndrome coronavirus 2","antibodies","coronavirus","coronavirus disease 2019","human coronavirus","neutralization","nucleocapsid protein","receptor-binding domain","respiratory infections","serologic analysis","spike protein","viruses","zoonoses"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1663609715795427329,"score":165.37894},{"pmid":32270413,"title":"A family cluster of severe acute respiratory syndrome coronavirus 2 infections.","text":["A family cluster of severe acute respiratory syndrome coronavirus 2 infections.","Clinical and epidemiological knowledge of 2019 novel coronavirus disease (COVID-19) is limited. We reported a family cluster of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cases in Beijing, China. This family comprised three laboratory confirmed cases with clinical symptoms. All three patients had close contact with a relative from Wuhan, Hubei Province. Throat swab samples were all positive for SARS-CoV-2 using real-time reverse transcriptase-polymerase chain reaction assays. Chest computerized tomography revealed ground-glass opacities and consolidation. SARS-CoV-2 infections tend to clusters. Physicians should be aware of contact history so that infected patients can be identified promptly and further spreading prevented.","Eur J Clin Microbiol Infect Dis","Gao, Xuesong","Yuan, Zheng","Yang, Di","Li, Hongjie","Zhang, Yijin","Gao, Ping","Liu, Xiaomin","Zhao, Wenshan","Xiao, Te","Duan, Xuefei","32270413"],"abstract":["Clinical and epidemiological knowledge of 2019 novel coronavirus disease (COVID-19) is limited. We reported a family cluster of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cases in Beijing, China. This family comprised three laboratory confirmed cases with clinical symptoms. All three patients had close contact with a relative from Wuhan, Hubei Province. Throat swab samples were all positive for SARS-CoV-2 using real-time reverse transcriptase-polymerase chain reaction assays. Chest computerized tomography revealed ground-glass opacities and consolidation. SARS-CoV-2 infections tend to clusters. Physicians should be aware of contact history so that infected patients can be identified promptly and further spreading prevented."],"journal":"Eur J Clin Microbiol Infect Dis","authors":["Gao, Xuesong","Yuan, Zheng","Yang, Di","Li, Hongjie","Zhang, Yijin","Gao, Ping","Liu, Xiaomin","Zhao, Wenshan","Xiao, Te","Duan, Xuefei"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32270413","week":"202015|Apr 06 - Apr 12","doi":"10.1007/s10096-020-03880-1","source":"PubMed","locations":["Beijing","Wuhan","China","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1663620082990841856,"score":157.30305},{"pmid":32245835,"title":"The Laboratory Diagnosis of COVID-19 Infection: Current Issues and Challenges.","text":["The Laboratory Diagnosis of COVID-19 Infection: Current Issues and Challenges.","The COVID-19 outbreak has had a major impact on clinical microbiology laboratories in the past several months. This commentary covers current issues and challenges for the laboratory diagnosis of infections caused by SARS-CoV-2. In the pre-analytical stage, collecting the proper respiratory tract specimen at the right time from the right anatomic site is essential for a prompt and accurate molecular diagnosis of COVID-19. Appropriate measures are required to keep laboratory staff safe while producing reliable test results. In the analytic stage, real-time RT-PCR assays remain the molecular test of choice for the etiologic diagnosis of SARS-CoV-2 infection while antibody-based techniques are being introduced as supplemental tools. In the postanalytical stage, testing results should be carefully interpreted using both molecular and serological findings. Finally, random access, integrated devices available at the point of care with scalable capacities will facilitate the rapid and accurate diagnosis and monitoring of SARS-CoV-2 infections and greatly assist in the control of this outbreak.","J Clin Microbiol","Tang, Yi-Wei","Schmitz, Jonathan E","Persing, David H","Stratton, Charles W","32245835"],"abstract":["The COVID-19 outbreak has had a major impact on clinical microbiology laboratories in the past several months. This commentary covers current issues and challenges for the laboratory diagnosis of infections caused by SARS-CoV-2. In the pre-analytical stage, collecting the proper respiratory tract specimen at the right time from the right anatomic site is essential for a prompt and accurate molecular diagnosis of COVID-19. Appropriate measures are required to keep laboratory staff safe while producing reliable test results. In the analytic stage, real-time RT-PCR assays remain the molecular test of choice for the etiologic diagnosis of SARS-CoV-2 infection while antibody-based techniques are being introduced as supplemental tools. In the postanalytical stage, testing results should be carefully interpreted using both molecular and serological findings. Finally, random access, integrated devices available at the point of care with scalable capacities will facilitate the rapid and accurate diagnosis and monitoring of SARS-CoV-2 infections and greatly assist in the control of this outbreak."],"journal":"J Clin Microbiol","authors":["Tang, Yi-Wei","Schmitz, Jonathan E","Persing, David H","Stratton, Charles W"],"date":"2020-04-05T11:00:00Z","year":2020,"_id":"32245835","week":"202014|Mar 30 - Apr 05","doi":"10.1128/JCM.00512-20","source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1663352135838859265,"score":157.05894},{"pmid":32302069,"title":"SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup.","text":["SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup.","In late 2019, cases of atypical pneumonia were detected in China. The etiological agent was quickly identified as a betacoronavirus (named SARS-CoV-2), which has since caused a pandemic. Several methods allowing for the specific detection of viral nucleic acids have been established, but these only allow detection of the virus during a short period of time, generally during acute infection. Serological assays are urgently needed to conduct serosurveys, to understand the antibody responses mounted in response to the virus, and to identify individuals who are potentially immune to re-infection. Here we describe a detailed protocol for expression of antigens derived from the spike protein of SARS-CoV-2 that can serve as a substrate for immunological assays, as well as a two-stage serological enzyme-linked immunosorbent assay (ELISA). These assays can be used for research studies and for testing in clinical laboratories. (c) 2020 The Authors. Basic Protocol 1: Mammalian cell transfection and protein purification Basic Protocol 2: A two-stage ELISA for high-throughput screening of human serum samples for antibodies binding to the spike protein of SARS-CoV-2.","Curr Protoc Microbiol","Stadlbauer, Daniel","Amanat, Fatima","Chromikova, Veronika","Jiang, Kaijun","Strohmeier, Shirin","Arunkumar, Guha Asthagiri","Tan, Jessica","Bhavsar, Disha","Capuano, Christina","Kirkpatrick, Ericka","Meade, Philip","Brito, Ruhi Nichalle","Teo, Catherine","McMahon, Meagan","Simon, Viviana","Krammer, Florian","32302069"],"abstract":["In late 2019, cases of atypical pneumonia were detected in China. The etiological agent was quickly identified as a betacoronavirus (named SARS-CoV-2), which has since caused a pandemic. Several methods allowing for the specific detection of viral nucleic acids have been established, but these only allow detection of the virus during a short period of time, generally during acute infection. Serological assays are urgently needed to conduct serosurveys, to understand the antibody responses mounted in response to the virus, and to identify individuals who are potentially immune to re-infection. Here we describe a detailed protocol for expression of antigens derived from the spike protein of SARS-CoV-2 that can serve as a substrate for immunological assays, as well as a two-stage serological enzyme-linked immunosorbent assay (ELISA). These assays can be used for research studies and for testing in clinical laboratories. (c) 2020 The Authors. Basic Protocol 1: Mammalian cell transfection and protein purification Basic Protocol 2: A two-stage ELISA for high-throughput screening of human serum samples for antibodies binding to the spike protein of SARS-CoV-2."],"journal":"Curr Protoc Microbiol","authors":["Stadlbauer, Daniel","Amanat, Fatima","Chromikova, Veronika","Jiang, Kaijun","Strohmeier, Shirin","Arunkumar, Guha Asthagiri","Tan, Jessica","Bhavsar, Disha","Capuano, Christina","Kirkpatrick, Ericka","Meade, Philip","Brito, Ruhi Nichalle","Teo, Catherine","McMahon, Meagan","Simon, Viviana","Krammer, Florian"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32302069","week":"202016|Apr 13 - Apr 19","doi":"10.1002/cpmc.100","keywords":["covid19","elisa","sars-cov-2","protein expression","serological assay"],"source":"PubMed","topics":["Mechanism"],"weight":1,"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664357978689503232,"score":155.14429},{"pmid":32194239,"title":"Transmission of COVID-19 in the terminal stage of incubation period: a familial cluster.","text":["Transmission of COVID-19 in the terminal stage of incubation period: a familial cluster.","We report a familial cluster of 2019 novel coronavirus disease (COVID-19) to evidence that a potential transmission of the COVID-19 during the incubation period. The first patient in this familial cluster was identified in presymptomatic period, as a close contact of a confirmed patient. Five family members had close contact with the first patient during his incubation period, four of them were confirmed to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the subsequent sampling test.","Int J Infect Dis","Li, Peng","Fu, Ji-Bo","Li, Ke-Feng","Chen, Yan","Wang, Hong-Ling","Liu, Lei-Jie","Liu, Jie-Nan","Zhang, Yong-Li","Liu, She-Lan","Tang, An","Tong, Zhen-Dong","Yan, Jian-Bo","32194239"],"abstract":["We report a familial cluster of 2019 novel coronavirus disease (COVID-19) to evidence that a potential transmission of the COVID-19 during the incubation period. The first patient in this familial cluster was identified in presymptomatic period, as a close contact of a confirmed patient. Five family members had close contact with the first patient during his incubation period, four of them were confirmed to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the subsequent sampling test."],"journal":"Int J Infect Dis","authors":["Li, Peng","Fu, Ji-Bo","Li, Ke-Feng","Chen, Yan","Wang, Hong-Ling","Liu, Lei-Jie","Liu, Jie-Nan","Zhang, Yong-Li","Liu, She-Lan","Tang, An","Tong, Zhen-Dong","Yan, Jian-Bo"],"date":"2020-03-21T11:00:00Z","year":2020,"_id":"32194239","week":"202012|Mar 16 - Mar 22","doi":"10.1016/j.ijid.2020.03.027","keywords":["COVID-19","SARS-CoV-2","cluster","incubation period"],"source":"PubMed","topics":["Transmission"],"weight":1,"_version_":1663352133471174656,"score":150.08682}]}